Skip to main content

linagliptin

Generic: LINAGLIPTIN·Brand: Glyxambi, Jentadueto, LINAGLIPTIN, TRADJENTA, Tradjenta, Trijardy

linagliptin: 2 clinical trials tracked.

linagliptin evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about linagliptin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

Effects of Liraglutide, Empagliflozin and Linagliptin on Mild Cognitive Impairment Remission in Type 2 Diabetes (LIGHT-MCI): A Multicentre, Randomised Controlled Trial With An Extension Phase

NCT05313529Registry updated 2026-01-06·N/A
Active, not recruiting

Primary endpoint: Mild cognitive impairment (MCI) remission rate

InterventionalRandomizedopen396 targetStarted 2022-10Completion 2026-075 sites · ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

NCT03281369Registry updated 2026-08-03·Phase 1/Phase 2
Terminated

Primary endpoint: Stage 1: Percentage of Participants With Objective Response (OR), as Determined by Investigator According to RECIST v1.1

InterventionalRandomizedopen219 enrolledStarted 2017-10Completion 2025-1028 sites · Australia, Israel, South Korea, Spain…Hoffmann-La Roche